Corindus

Corindus designs and develops robotic systems for coronary and peripheral vascular intervention procedures.

Business Model:

Revenue: $15.2M

Employees: 51-200

Detailed Corindus Information

Corindus was acquired by Siemens Healthineers.
The acquisition happend on 2019-08-08.
Details of the transaction were not public

Geographic Data

Corindus headquarters map

Address: 309 Waverley Oaks Road

City: Waltham

State: MA

Zip: 02452

Country: US

Financial Info

Stage:

post ipo equity

Raised Last:

$20M

Raised Total:

$117M

Metrics

1,855,942Website Global Rank

12,035Website Monthly Traffic

Twitter Followers

Description

Corindus designs and develops robotic systems for coronary and peripheral vascular intervention procedures.

Contact Phone:
+15086533335

Contact Email:

Corindus went public on 8/19/2014 on the Other

Listed Exchange:
Other

IPO Date:
8/19/2014

Ticker Symbol:
CVRS

IPO Price:
$3.8/share

Amount Raised:
$42M

Live

Opened: -/share

EBITDA -
Total Cash -
Total Debt -
Total Revenue -
Total Profit (Gross) -
PE Ratio -
Announced Date Company Transaction Money Raised
11/2019 XACT Robotics Series D 36M
11/2019 XACT Robotics Series D 0
Announced Date Transaction Number of Investors Money Raised Lead Investors
3/2018 Post-IPO Debt 2 $23M Solar capital
Silicon Valley Bank
Silicon Valley Bank
Solar capital
Solar capital
Silicon Valley Bank
Silicon Valley Bank
Solar capital
3/2018 Post-IPO Equity $0 Hudson Executive Capital
BioStar Capital
Hudson Executive Capital
BioStar Capital
3/2019 Unattributed $413.9k
3/2019 Equity $4.8M
2/2019 Private Placement $15M
3/2018 Unattributed $180k
11/2009 Debt Financing $4.7M
9/2014 Post-IPO Equity $26.6M
2/2019 Post-IPO Equity $0 BioStar Capital
Hudson Executive Capital
BioStar Capital
Hudson Executive Capital
11/2009 Series C $5.3M
2/2017 Post-IPO Equity 1 $45M BioStar Capital
BioStar Capital
BioStar Capital
BioStar Capital
5/2015 Post-IPO Equity $41.8M
4/2008 Series B $0 Technion Research &a; Development Foundation
Hudson Executive Capital
20/20 Capital Group
Consonance Capital Partners
BioStar Capital
Boston Scientific Neuromodulation Corporation
HealthCor Partners
Technion Research &a; Development Foundation
Hudson Executive Capital
20/20 Capital Group
Consonance Capital Partners
BioStar Capital
Boston Scientific Neuromodulation Corporation
HealthCor Partners
3/2018 Series A 2 $25M Hudson Executive Capital
BioStar Capital
2/2019 Post-IPO Equity 2 $19.5M BioStar Capital
Hudson Executive Capital
BioStar Capital
Hudson Executive Capital
4/2008 Series B 7 $12M Technion Research &a; Development Foundation
Hudson Executive Capital
20/20 Capital Group
Technion Research &a; Development Foundation
Hudson Executive Capital
20/20 Capital Group
Announced Date Name Price

Employee Departments

Employee States

Uniview Singapore VEID Logo
Uniview Singapore VEID
Revenue: 0 - 100000
Employees:
Industry: Software
Details
Konkuk University Medical Center Logo
Konkuk University Medical Center
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Education
Details
Daemon Technologies Logo
Daemon Technologies
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Blockchain
Details
Ace International Trade Logo
Ace International Trade
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Industrial
Details
An Hòa Communications Logo
An Hòa Communications
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Advertising
Details

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research